SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-020093
Filing Date
2023-07-18
Accepted
2023-07-18 09:06:26
Documents
16
Period of Report
2023-07-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20230703_8k.htm   iXBRL 8-K 34980
2 EXHIBIT 10.1 ex_540847.htm EX-10.1 145571
3 EXHIBIT 99.1 ex_541793.htm EX-99.1 17949
8 a01.jpg GRAPHIC 7436
  Complete submission text file 0001437749-23-020093.txt   377146

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20230714.xsd EX-101.SCH 3409
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20230714_def.xml EX-101.DEF 11804
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20230714_lab.xml EX-101.LAB 15848
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20230714_pre.xml EX-101.PRE 12019
10 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20230703_8k_htm.xml XML 2637
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 231093127
SIC: 2834 Pharmaceutical Preparations